Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
65.79
+2.15 (3.38%)
At close: Jun 26, 2026, 4:00 PM EDT
65.80
+0.01 (0.02%)
After-hours: Jun 26, 2026, 7:28 PM EDT
Bright Minds Biosciences Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Bright Minds Biosciences stock have an average target of 143.83, with a low estimate of 80 and a high estimate of 220. The average target predicts an increase of 118.62% from the current stock price of 65.79.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Bright Minds Biosciences stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $145 | Buy | Reiterates | $145 | +120.40% | Jun 25, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $190 → $220 | Buy | Reiterates | $190 → $220 | +234.40% | May 20, 2026 |
| Jefferies | Jefferies | Buy Initiates $145 | Buy | Initiates | $145 | +120.40% | Apr 12, 2026 |
| BTIG | BTIG | Buy Maintains $147 | Buy | Maintains | $147 | +123.44% | Mar 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
33.61M
EPS This Year
-6.05
from -1.78
EPS Next Year
-12.09
from -6.05
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 235.3M | |
| Avg | n/a | 33.6M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | -100.0% |
| Avg | - | -100.0% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -6.05 | -12.09 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.